Combs, S. E., Rieken, S., Wick, W., Abdollahi, A., von Deimling, A., Debus, J., & Hartmann, C. (2011). Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: One step forward, and one step back? BioMed Central.
Chicago-stil citatCombs, Stephanie E., Stefan Rieken, Wolfgang Wick, Amir Abdollahi, Andreas von Deimling, Jürgen Debus, och Christian Hartmann. Prognostic Significance of IDH-1 and MGMT in Patients With Glioblastoma: One Step Forward, and One Step Back? BioMed Central, 2011.
MLA-referensCombs, Stephanie E., et al. Prognostic Significance of IDH-1 and MGMT in Patients With Glioblastoma: One Step Forward, and One Step Back? BioMed Central, 2011.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.